• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative percent of CDRH 2013 Strategic Priorities actions listed in the plan as completed (1)

Dictionary: CDRH seeks to continually improve its effectiveness in fulfilling its mission by planning strategically and regularly monitoring progress. CDRH has identified priority areas of activity for each year, each of which presents significant opportunities to improve the Center’s effectiveness in fulfilling its mission. This measure tracks the completion of actions the Center will take in order to meet time-bound goals associated with the strategies the Center is implementing in alignment with the identified priorities.

Information is current as of December 31, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeCumulative Annual TargetCumulative Percent
Jan 2013N/A5
Feb 2012N/A5
Mar 2013N/A10
Apr 2013N/A13
May 2013N/A15
Jun 2013N/A18
Jul 2013N/A28
Aug 2013N/A38
Sep 2013N/A77
Oct 2013N/A77
Nov 2013N/A77
Dec 2013N/A77

Footnotes

  • (1) CDRH released its 2013 Strategic Plan in January 2013. The plan covers the 2013 Calendar Year (CY).

Cumulative number of CDRH 2013 Strategic Priorities actions listed in the plan completed (1)

Cumulative CY 2013 Target: 33 of 39 2013 plan actions by 12/31/2013

Fiscal Year - 2013
Skip graphic and jump to text data.

Cumulative CY 2013 Target: 33 of 39 2013 plan actions by 12/31/2013

TimeCumulative Annual TargetCumulative Number
Jan 2013332
Feb 2012332
Mar 2013334
Apr 2013335
May 2013336
Jun 2013337
Jul 20133311
Aug 20133315
Sep 20133330
Oct 20133330
Nov 20133330
Dec 20133330

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.